Remove Clinical Research Remove International Remove Pharma Companies
article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Sponsors often contract a CRO to delegate specific day-to-day tasks, streamlining their research processes and enhancing efficiency. Patient recruitment and retention : Recruiting and retaining a sufficient number of eligible participants is one of the major challenges in conducting clinical trials.

article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. The challenge of partnering with Big Pharma . Which areas of drug discovery research stand to benefit most? .

article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 189
article thumbnail

The History and Development of Pinnacle 21

Quanticate

Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time. By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards.

article thumbnail

Pfizer CMO Steps Down, Stanford Professor to Transition into Role

The Pharma Data

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. I have every confidence in her continued success in this new role,” Rothenberg said. program and Institute for Immunity, Transplantation and Infection.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

Quantifying the use of connected digital products in clinical research. Clinical Trial Tweaks Forced by Virus Should Stay, Hahn Says. He shares some of the questions the industry at large should be asking itself as we move into 2023: “What unmet needs exist today, and what are the opportunities for commercial success?